Sandra Milligan

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
6 years
Director since
2023

6 years of board service in total across 2 boards, counting each seat separately. Longest: Gossamer Bio Inc., 3 years.

3 years · Since 2023
2 years · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 19, 2025 Gossamer Bio Inc. Open-market purchase +26,050 $1.92 $50,016
Nov 15, 2023 Gossamer Bio Inc. Open-market purchase +32,000 $0.79 $25,280
May 4, 2023 Organon & Co. Option exercise +4,984 — —
May 4, 2023 Organon & Co. Shares withheld for tax −2,168 $24.24 $52,552
May 1, 2023 Organon & Co. Option exercise +1,899 — —
May 1, 2023 Organon & Co. Shares withheld for tax −826 $24.63 $20,344
Mar 31, 2023 Organon & Co. Option exercise +5,964 — —
Mar 31, 2023 Organon & Co. Shares withheld for tax −2,115 $23.09 $48,835

Questions about Sandra Milligan

What boards is Sandra Milligan on?

Sandra Milligan sits on the boards of Gossamer Bio Inc. and Spyre Therapeutics Inc.

How long has Sandra Milligan served on boards?

Our records show at least 6 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.